| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.008 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |